II. Diagnosis: Binge-Eating Disorder (DSM-5)
- Recurrent Binge Eating (eating more than peers in a 2 hour period) with a sense of loss of control
- No behaviors to prevent weight gain
- Contrast with Bulimia Nervosa
- Weekly behaviors (3 months or more)
- Fast eating, uncomfortable after eating, eating large quantities when not hungry
- Embarrassed about Overeating (e.g. eating alone due to embarrassment)
- Guilt or depression related to Binge Eating
- Severity
- Mild: 1 to 3 episodes per week
- Moderate: 4 to 7 episodes per week
- Severe: 8 to 13 episodes per week
- Extreme: >14 episodes per week
III. Findings: Compulsive Overeating
- Uncontrolled consumption of large food amounts
- Eat for relief, comfort, nurturing
- Stress
- Boredom
- Fear
- Loneliness
- Plan the Next meal while eating this one
- Eat more than you want, or out of control with food
- Binge Eating
- Excessive intake per 2 hour period
- Grazing
- Large food intake throughout day, no planned meals
- Guilt and fear about not being able to stop eating
- Eat until feeling uncomfortably full
- Binge Eating
- Surreptitious eating
- Eating alone because of shame about excessive eating
- Sense of being fat or obese, or fear of becoming so
- Sought help or attempted methods to control weight
- Frequent weight fluctuations exceeding 10 pounds
IV. Differential Diagnosis
- Bulimia Nervosa (contrast with no compensatory purging in binge-eating)
V. Management
- Binge-Eating cessation
- Cognitive Behavioral Therapy
- Preferred first-line behavioral intervention
- Interpersonal psychotherapy
- Evaluate past and current symptoms
- Relate symptoms to patient's interpersonal and social context
- Self help programs
- May be used as adjuncts to formal therapy
- Cognitive Behavioral Therapy
- Manage comorbid Major Depression
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Sertraline, Citalopram and Escitalopram have most evidence for use
- Selective Serotonin Reuptake Inhibitors (SSRI)
-
Weight Reduction (in combination with Cognitive Behavioral Therapy)
- See Obesity Management
- Orlistat
- Sibutramine
- Other agents to control binging and also assist with weight loss
- Other agents
- Lisdexamfetamine (Vyvanse)
- Consider in adults with >3 days of Binge Eating per week, refractory to other agents
- Postulated to act at Dopamine-based reward centers
- Dosing starts at 30 mg daily and titrate weekly to 50 to 70 mg daily
- (2015) Presc Lett 22(3):17
- Lisdexamfetamine (Vyvanse)
VI. Complications
- Complications related to Obesity (present in 71% of cases)
- Metabolic Syndrome and Type II Diabetes Mellitus
- Osteoarthritis
- Gastrointestinal symptoms
- Gastroesophageal Reflux
- Altered stool habits (Constipation, Diarrhea)
- Abdominal Bloating
VII. References
- Renbarger and Pearson (2021) Crit Dec Emerg Med 35(8): 17-23
- Klein (2021) Am Fam Physician 103(1): 22-32 [PubMed]